Resveratrol: Is selectivity opening the key to therapeutic effects?

Metabolism: Clinical and Experimental

Volumn 61, Issue 3, 2012, Pages 289-290

  Lee, Seung Hwan ^a   Mantzoros, Christos ^a   Kim, Young Bum ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; HISTONE DEACETYLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT HISTONE DEACETYLASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RESVERATROL; SIRTUIN 1; UNCLASSIFIED DRUG;

ADIPOCYTE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SELECTIVITY; EDITORIAL; ENZYME PHOSPHORYLATION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESPAN; LONGEVITY; LOW DRUG DOSE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SURVIVAL RATE; WHITE ADIPOSE TISSUE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; INSULIN; INSULIN RESISTANCE; MALE; SIGNAL TRANSDUCTION; STILBENES;

EID: 84857501352     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.09.015     Document Type: Editorial

References (20)

1. J.C. Milne, P.D. Lambert, and S. Schenk Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes Nature 450 2007 712 716 (Pubitemid 350207685)
2. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493 506 (Pubitemid 44136961)
3. F.Z. Marques, M.A. Markus, and B.J. Morris Resveratrol: cellular actions of a potent natural chemical that confers a diversity of health benefits Int J Biochem Cell Biol 41 2009 2125 2128
4. O. Vang, N. Ahmad, and C.A. Baile What is new for an old molecule? Systematic review and recommendations on the use of resveratrol PLoS One 6 2011 e19881
5. J.A. Baur, K.J. Pearson, and N.L. Price Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342 (Pubitemid 44764104)
6. L. Bordone, and L. Guarente Calorie restriction, SIRT1 and metabolism: understanding longevity Nat Rev Mol Cell Biol 6 2005 298 305 (Pubitemid 40516896)
7. M. Blüher, B.B. Kahn, and C.R. Kahn Extended longevity in mice lacking the insulin receptor in adipose tissue Science 299 2003 572 574 (Pubitemid 36135156)
8. W. Kang, H.J. Hong, and J. Guan Resveratrol improves insulin signaling in a tissue specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents Metabolism 61 2012 424 433
9. M. Lagouge, C. Argmann, and Z. Gerhart-Hines Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α Cell 127 2006 1109 1122 (Pubitemid 44894520)
10. C. Sun, F. Zhang, and X. Ge SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B Cell Metab 6 2007 307 319 (Pubitemid 47468091)
11. L.L. Chen, H.H. Zhang, and J. Zheng Resveratrol attenuates high-fat diet-induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial β-oxidation Metabolism 2011 [Epub ahead of print]
12. K.J. Pearson, J.A. Baur, and K.N. Lewis Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending lifespan Cell Metab 8 2008 157 168
13. Y. Hu, J. Liu, and J. Wang The controversial links among calorie restriction, SIRT1, and resveratrol Free Radic Biol Med 51 2011 250 256
14. J.H. Um, S.J. Park, and H. Kang AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol Diabetes 59 2010 554 563
15. M. Suwa, H. Nakano, and Z. Radak Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide- 1-β-d-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle Metabolism 60 2011 394 403
16. C. Centeno-Baez, P. Dallaire, and A. Marette Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1 Am J Physiol Endocrinol Metab 2011 [Epub ahead of print]
17. D. Chen, J. Bruno, and E. Easlon Tissue-specific regulation of SIRT1 by calorie restriction Genes Dev 22 2008 1753 1757 (Pubitemid 351915500)
18. J. Zhang Resveratrol inhibits insulin responses in a SirT1-independent pathway Biochem J 397 2006 519 527 (Pubitemid 44187510)
19. S. Fröjdö, D. Cozzone, and H. Vidal Resveratrol is a class IA phosphoinositide 3-kinase inhibitor Biochem J 406 2007 511 518 (Pubitemid 47425457)
20. K.R. Patel, E. Scott, and V.A. Brown Clinical trials of resveratrol Ann N Y Acad Sci 1215 2011 161 169